E-LIB Suche - Ergebnisse für: Takuya Tsujino

1

Durable Response to Enfortumab Vedotin Compared to Re-chall..:

Uchimoto, Taizo ; Tsuchida, Shuya ; Komura, Kazumasa...
Targeted Oncology. 19 (2024) 3 - p. 401-410 , 2024

2

Prognostic Impact of Immune-Related Adverse Events as First..:

Nukaya, Takuhisa ; Takahara, Kiyoshi ; Yoshizawa, Atsuhiko...
Clinical Genitourinary Cancer. 22 (2024) 1 - p. 76-83 , 2024

Link: https://doi.org/10.1016/..

3

Comparison of the efficacy of enfortumab vedotin between pa..:

Hirasawa, Yosuke ; Adachi, Takahiro ; Hashimoto, Takeshi...
Journal of Cancer Research and Clinical Oncology. 150 (2024) 4 - p. , 2024

Link: https://doi.org/10.1007/..

4

C-Reactive Protein-Albumin Ratio Predicts Objective Respons..:

Uchimoto, Taizo ; Matsuda, Takuya ; Komura, Kazumasa...
Targeted Oncology. 19 (2024) 4 - p. 635-644 , 2024

Link: https://doi.org/10.1007/..

5

CRISPR screens reveal genetic determinants of PARP inhibito..:

Tsujino, Takuya ; Takai, Tomoaki ; Hinohara, Kunihiko...
Nature Communications. 14 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

6

The Impact of FGFR3 Alterations on the Tumor Microenvironme..:

Komura, Kazumasa ; Hirosuna, Kensuke ; Tokushige, Satoshi...
Molecular Cancer. 22 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

7

Nephron-sparing ureteroscopic surgery vs. radical nephroure..:

Tsujino, Takuya ; Komura, Kazumasa ; Inamoto, Teruo...
World Journal of Urology. 41 (2023) 12 - p. 3585-3591 , 2023

Link: https://doi.org/10.1007/..

8

Real world evidence of enfortumab vedotin in patients with ..:

Fukuokaya, Wataru ; Koike, Yuhei ; Yata, Yuji...
International Journal of Urology. 31 (2023) 4 - p. 342-347 , 2023

Link: https://doi.org/10.1111/..

9

Expression of Preferentially Expressed Antigen in Melanoma,..:

Fujii, Shota ; Ishida, Mitsuaki ; Komura, Kazumasa...
Diagnostics. 13 (2023) 24 - p. 3636 , 2023

Link: https://doi.org/10.3390/..

10

Tertiary lymphoid structure and neutrophil–lymphocyte ratio..:

Komura, Kazumasa ; Tokushige, Satoshi ; Ishida, Mitsuaki...
Cancer Science. 114 (2023) 12 - p. 4622-4631 , 2023

Link: https://doi.org/10.1111/..

11

Real‑world survival outcome comparing abiraterone acetate p..:

Tsujino, Takuya ; Tokushige, Satoshi ; Komura, Kazumasa...
Cancer Medicine. 12 (2023) 19 - p. 19414-19422 , 2023

Link: https://doi.org/10.1002/..

12

Serum C-reactive Protein Level Predicts Overall Survival fo..:

Yano, Yusuke ; Ohno, Takaya ; Komura, Kazumasa...
Cancers. 14 (2022) 22 - p. 5659 , 2022

Link: https://doi.org/10.3390/..

13

Efficacy of pembrolizumab and comprehensive CD274/PD-L1 pro..:

Nishimura, Kazuki ; Nishio, Kyosuke ; Hirosuna, Kensuke...
Journal for ImmunoTherapy of Cancer. 10 (2022) 1 - p. e003868 , 2022

Link: https://doi.org/10.1136/..

14

Prognostic value of the fluctuation in the neutrophil–lymph..:

Uchimoto, Taizo ; Nakamura, Ko ; Komura, Kazumasa...
Urologic Oncology: Seminars and Original Investigations. 40 (2022) 7 - p. 344.e11-344.e17 , 2022

Link: https://doi.org/10.1016/..

15

Risk Classification for Overall Survival by the Neutrophil–..:

Uchimoto, Taizo ; Komura, Kazumasa ; Fukuokaya, Wataru...
Cancers. 13 (2021) 14 - p. 3554 , 2021

Link: https://doi.org/10.3390/..